Influenza virus shedding in laninamivir-treated children upon returning to school

Tohoku Journal of Experimental Medicine

Volumn 238, Issue 2, 2016, Pages 113-121

  Kondo, Hiroki ^a   Shobugawa, Yugo ^a   Hibino, Akinobu ^a   Yagami, Ren ^a   Dapat, Clyde ^b   Okazaki, Minoru ^c   Otsuka, Taketo ^a   Fujii, Koyata ^d   Hassan, Mohd Rohaizat ^a,e   Saito, Reiko ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Sado General Hospital   (Japan)

^d Department of Pediatrics   (Japan)

^e UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Influenza; Laninamivir; Period of school absence; School health; Virus shedding

Indexed keywords

LANINAMIVIR; VIRUS RNA; ANTIVIRUS AGENT; SIALIDASE; ZANAMIVIR;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INFECTION RATE; INFLUENZA A (H3N2); INFLUENZA B VIRUS; MALE; NOSE SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL REENTRY; SEASONAL INFLUENZA; SEASONAL VARIATION; VIRUS DETECTION; VIRUS LOAD; VIRUS SHEDDING; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DEMOGRAPHY; DRUG EFFECTS; GENETICS; HEALTH; INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; METABOLISM; SCHOOL; VIROLOGY;

ANTIVIRAL AGENTS; CHILD; DEMOGRAPHY; FEMALE; HEALTH; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MALE; NEURAMINIDASE; RNA, VIRAL; SCHOOLS; VIRUS SHEDDING; ZANAMIVIR;

EID: 84955490666     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.238.113     Document Type: Article

References (46)

1. Chambers, B.S., Li, Y., Hodinka, R.L. & Hensley, S.E. (2014) Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J. Virol., 88, 10986-10989.
2. Cox, N.J. & Subbarao, K. (2000) Global epidemiology of influenza: past and present. Annu. Rev. Med., 51, 407-421.
3. Dapat, C., Kondo, H., Dapat, I.C., Baranovich, T., Suzuki, Y., Shobugawa, Y., Saito, K., Saito, R. & Suzuki, H. (2013) Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan. Antiviral Res., 99, 261-269.
4. Dapat, C., Saito, R., Kyaw, Y., Naito, M., Hasegawa, G., Suzuki, Y., Dapat, I.C., Zaraket, H., Cho, T.M., Li, D., Oguma, T., Baranovich, T. & Suzuki, H. (2009) Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007. Intervirology, 52, 310-320.
5. Dapat, I.C., Dapat, C., Baranovich, T., Suzuki, Y., Kondo, H., Shobugawa, Y., Saito, R. & Suzuki, H.; Japanese Influenza Collaborative Study Group (2012) Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan. PLoS One, 7, e36455.
6. Daum, L.T., Canas, L.C., Arulanandam, B.P., Niemeyer, D., Valdes, J.J. & Chambers, J.P. (2007) Real-time RT-PCR assays for type and subtype detection of influenza A and B viruses. Influenza Other Respir. Viruses, 1, 167-175.
7. Dobson, J., Whitley, R.J., Pocock, S. & Monto, A.S. (2015) Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet, 385, 1729-1737.
8. Farrukee, R., Leang, S.K., Butler, J., Lee, R.T., Maurer-Stroh, S., Tilmanis, D., Sullivan, S., Mosse, J., Barr, I.G. & Hurt, A.C. (2015) Influenza viruses with B/Yamagata- and B/Victorialike neuraminidases are differentially affected by mutations that alter antiviral susceptibility. J. Antimicrob. Chemother., 70, 2004-2012.
9. Hata, A., Akashi-Ueda, R., Takamatsu, K. & Matsumura, T. (2014) Safety and efficacy of peramivir for influenza treatment. Drug Des. Devel. Ther., 8, 2017-2038.
10. Hoffmann, E., Stech, J., Guan, Y., Webster, R.G. & Perez, D.R. (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol., 146, 2275-2289.
11. Ikematsu, H. & Kawai, N. (2011) Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev. Anti Infect. Ther., 9, 851-857.
12. Ikematsu, H., Kawai, N., Iwaki, N. & Kashiwagi, S. (2014a) Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: comparison between the 2011- 2012 and 2012-2013 influenza seasons. J. Infect. Chemother., 20, 799-803.
13. Ikematsu, H., Kawai, N., Iwaki, N. & Kashiwagi, S. (2014b) The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011-2012 influenza season. J. Infect. Chemother., 20, 81-85.
14. Ikematsu, H., Kawai, N., Iwaki, N. & Kashiwagi, S. (2015a) In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season. J. Infect. Chemother., 21, 39-42.
15. Ikematsu, H., Kawai, N., Iwaki, N. & Kashiwagi, S. (2015b) Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013-2014 Japanese season. J. Infect. Chemother., 21, 802-807.
16. Kawai, N., Ikematsu, H., Iwaki, N., Kondou, K., Hirotsu, N., Kawashima, T., Maeda, T., Tanaka, O., Doniwa, K. & Kashiwagi, S. (2009) Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation. J. Infect., 59, 207-212.
17. Kawai, N., Ikematsu, H., Iwaki, N., Maeda, T., Satoh, I., Hirotsu, N. & Kashiwagi, S. (2006) A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin. Infect. Dis., 43, 439-444.
18. Koseki, N., Kaiho, M., Kikuta, H., Oba, K., Togashi, T., Ariga, T. & Ishiguro, N. (2014) Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011-2012 season. Influenza Other Respir. Viruses, 8, 151-158.
19. LaBarre, D.D. & Lowy, R.J. (2001) Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays. J. Virol. Methods, 96, 107-126.
20. Leang, S.K., Kwok, S., Sullivan, S.G., Maurer-Stroh, S., Kelso, A., Barr, I.G. & Hurt, A.C. (2014) Peramivir and laninamivir susceptibility of circulating influenza A and B viruses. Influenza Other Respir. Viruses, 8, 135-139.
21. Ministry of Health, Labour and Welfare (2012) Infection Control Guidelines for nursery. Revised version in 2012. http://www.mhlw.go.jp/bunya/kodomo/pdf/hoiku02.pdf [Accessed: December 8, 2015].
22. Mizuno, T., Mizuno, S. & Kanda, T. (2014) Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection. PLoS One, 9, e92601.
23. Monto, A.S., McKimm-Breschkin, J.L., Macken, C., Hampson, A.W., Hay, A., Klimov, A., Tashiro, M., Webster, R.G., Aymard, M., Hayden, F.G. & Zambon, M. (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob. Agents Chemother., 50, 2395-2402.
24. Murtaugh, W., Mahaman, L., Healey, B., Peters, H., Anderson, B., Tran, M., Ziese, M. & Carlos, M.P. (2013) Evaluation of three influenza neuraminidase inhibition assays for use in a public health laboratory setting during the 2011-2012 influenza season. Public Health Rep., 128 Suppl 2, 75-87.
25. Neumann, G., Noda, T. & Kawaoka, Y. (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 459, 931-939.
26. Nguyen, H.T., Sheu, T.G., Mishin, V.P., Klimov, A.I. & Gubareva, L.V. (2010) Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob. Agents Chemother., 54, 3671-3677.
27. Okomo-Adhiambo, M., Sleeman, K., Ballenger, K., Nguyen, H.T., Mishin, V.P., Sheu, T.G., Smagala, J., Li, Y., Klimov, A.I. & Gubareva, L.V. (2010) Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective. Viruses, 2, 2269-2289.
28. Okomo-Adhiambo, M., Sleeman, K., Lysen, C., Nguyen, H.T., Xu, X., Li, Y., Klimov, A.I. & Gubareva, L.V. (2013) Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. Influenza Other Respir. Viruses, 7, 645-658.
29. Saito, R., Sato, I., Suzuki, Y., Baranovich, T., Matsuda, R., Ishitani, N., Dapat, C., Dapat, I.C., Zaraket, H., Oguma, T. & Suzuki, H. (2010) Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation. Pediatr. Infect. Dis. J., 29, 898-904.
30. Shobugawa, Y., Saito, R., Sato, I., Kawashima, T., Dapat, C., Dapat, I.C., Kondo, H., Suzuki, Y., Saito, K. & Suzuki, H. (2012) Clinical effectiveness of neuraminidase inhibitors– oseltamivir, zanamivir, laninamivir, and peramivir–for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan. J. Infect. Chemother., 18, 858-864.
31. Suess, T., Remschmidt, C., Schink, S.B., Schweiger, B., Heider, A., Milde, J., Nitsche, A., Schroeder, K., Doellinger, J., Braun, C., Haas, W., Krause, G. & Buchholz, U. (2012) Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011. PLoS One, 7, e51653.
32. Sugaya, N. (2011) Widespread use of neuraminidase inhibitors in Japan. J. Infect. Chemother., 17, 595-601.
33. Sugaya, N., Mitamura, K., Yamazaki, M., Tamura, D., Ichikawa, M., Kimura, K., Kawakami, C., Kiso, M., Ito, M., Hatakeyama, S. & Kawaoka, Y. (2007) Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin. Infect. Dis., 44, 197-202.
34. Sugaya, N. & Ohashi, Y. (2010) Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob. Agents Chemother., 54, 2575-2582.
35. Sugaya, N., Sakai-Tagawa, Y., Bamba, M., Yasuhara, R., Yamazaki, M., Kawakami, C., Yamaguchi, Y., Ide, Y., Ichikawa, M., Mitamura, K. & Kawaoka, Y. (2015) Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor. Antivir. Ther., 20, 49-55.
36. Suzuki, H., Saito, R., Masuda, H., Oshitani, H., Sato, M. & Sato, I. (2003) Emergence of amantadine-resistant influenza A viruses: epidemiological study. J. Infect. Chemother., 9, 195-200.
37. Suzuki, Y., Saito, R., Sato, I., Zaraket, H., Nishikawa, M., Tamura, T., Dapat, C., Caperig-Dapat, I., Baranovich, T., Suzuki, T. & Suzuki, H. (2011) Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method. J. Clin. Microbiol., 49, 125-130.
38. Suzuki, Y., Saito, R., Zaraket, H., Dapat, C., Caperig-Dapat, I. & Suzuki, H. (2010) Rapid and specific detection of amantadine- resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method. J. Clin. Microbiol., 48, 57-63.
39. Takayama, K. (2010) Recent tasks of school health administration in Japan. JMAJ, 53, 144-147.
40. Takemoto, Y., Asai, T., Ikezoe, I., Yano, T., Ichikawa, M., Miyagawa, S. & Matsumoto, J. (2013) Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013. Chemotherapy, 59, 373-378.
41. Tamura, D., Okomo-Adhiambo, M., Mishin, V.P., Guo, Z., Xu, X., Villanueva, J., Fry, A.M., Stevens, J. & Gubareva, L.V. (2015) Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses. Antimicrob. Agents Chemother., 59, 2374-2379.
42. Tamura, D., Sugaya, N., Ozawa, M., Takano, R., Ichikawa, M., Yamazaki, M., Kawakami, C., Shimizu, H., Uehara, R., Kiso, M., Kawakami, E., Mitamura, K. & Kawaoka, Y. (2011) Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin. Infect. Dis., 52, 432-437.
43. Thorlund, K., Awad, T., Boivin, G. & Thabane, L. (2011) Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect. Dis., 11, 134.
44. Watanabe, A., Chang, S.C., Kim, M.J., Chu, D.W. & Ohashi, Y.; MARVEL Study Group (2010) Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial. Clin. Infect. Dis., 51, 1167-1175.
45. Wright, P.F. & Webster, R.G. (2001) Orthomyxoviridae. Chapter 47. In Fields virology, 4th ed. edited by Knipe, D.M. & Howley, P.M. Philadelphia, pp. 1562.
46. Yates, P.J., Mehta, N., Horton, J. & Tisdale, M. (2013) Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza. Antimicrob. Agents. Chemother., 57, 1677-1684.